Support homeIn Situ Gene ExpressionDocumentationExperimental Design & Planning
Xenium In Situ Gene and Protein Expression Validated Tissue List

Xenium In Situ Gene and Protein Expression Validated Tissue List

List of human FFPE tissue types that were validated in-house with Xenium In Situ Gene and Protein Expression with Cell Segmentation Staining (CG000819). Xenium Gene and Protein Expression success depends on stain quality, which in turn, depends on sample quality and tissue cell type composition. Tissues tested in-house were acquired from biobanks. All tissues listed below were processed per our standard documentation following FFPE Tissue Preparation (CG000578) and Xenium In Situ Gene and Protein Expression (CG000819).

Some tissues were tested with multiple tissue states. Example datasets can be found here.

TissueDisease statePrimary DiagnosisImportant Considerations
TonsilDiseasedLymphoid hyperplasia
Lymph nodeDiseased / non-diseasedDiffuse Large B cell Lymphoma, Follicular Lymphoma
BreastDiseasedIDC triple positive / negative, Invasive ductal carcinoma, Infiltrating lobular carcinoma
ColonDiseased / non-diseasedAdenocarcinoma
AppendixDiseased / non-diseasedCrohn’s disease/ Invasive Mucinous Adenocarcinoma
LungDiseased / non-diseasedInflammation, Adenocarcinoma
KidneyDiseased / non-diseasedClear cell carcinoma
SkinDiseased / non-diseasedMelanoma, Basal cell carcinomaEven though skin can be prone to detachment, recommend following the User Guide as written for decrosslinking conditions.
LiverDiseased / non-diseasedHepatocellular carcinoma
OvaryDiseasedSerous carcinoma
SpleenDiseasedInflammation
Small intestineDiseased / non-diseasedColorectal Cancer
PancreasNon-diseased
ProstateDiseasedAdenocarcinoma
BrainDiseasedGlioblastoma
Document Type
Specifications

Last Modified
August 18, 2025